ZSPH Insider Trading Activity and SEC Form 4 Filings
ZSPH insider trading summary
No open-market insider purchases or sales of ZS Pharma, Inc. (ZSPH) have been reported on SEC Form 4 in the past 12 months.
Latest ZSPH insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 21, 2015 | Todd A Creech | Insider | Sell | $2.5M (50,000 @ $49.76) |
| Aug 20, 2015 | Todd A Creech | Insider | Sell | $1.0M (20,000 @ $50.03) |
| Jun 8, 2015 | Alta Partners VIII, L.P. | 10% Owner | Sell | $644K (11,200 @ $57.53) |
| Jun 8, 2015 | Alta Partners Management VIII, LLC | 10% Owner | Sell | $644K (11,200 @ $57.53) |
| Jun 8, 2015 | Daniel Janney | 10% Owner | Sell | $644K (11,200 @ $57.53) |
| Jun 8, 2015 | Guy P Nohra | Director | Sell | $644K (11,200 @ $57.53) |
| Jun 8, 2015 | Farah Champsi | 10% Owner | Sell | $644K (11,200 @ $57.53) |
| Jun 5, 2015 | Alta Partners Management VIII, LLC | 10% Owner | Sell | $9.5M (164,227 @ $57.88) |
| Jun 5, 2015 | Farah Champsi | 10% Owner | Sell | $9.5M (164,227 @ $57.88) |
| Jun 5, 2015 | Daniel Janney | 10% Owner | Sell | $9.5M (164,227 @ $57.88) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.